A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-60761-500-2_11PMID 20204730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in pulmonary arterial hypertension.

  2012cited by this paper
• Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance

  2008cited by this paper
• Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells.

  2008cited by this paper
• Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation.

  2008cited by this paper
• Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations.

  2008cited by this paper
• Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.

  2008cited by this paper
• Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.

  2008cited by this paper
• Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.

  2007cited by this paper
• The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

  2007cited by this paper
• A USA-based registry for pulmonary arterial hypertension: 1982–2006

  2007cited by this paper
• Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines

  2007cited by this paper
• Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.

  2007cited by this paper
• Integrated molecular profiling of SOD2 expression in multiple myeloma.

  2007cited by this paper
• A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

  2007cited by this paper
• Transgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary Hypertension

  2006cited by this paper
• An Abnormal Mitochondrial–Hypoxia Inducible Factor-1&agr;–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats: Similarities to Human Pulmonary Arterial Hypertension

  2006cited by this paper
• A central role for oxygen-sensitive K+ channels and mitochondria in the specialized oxygen-sensing system.

  2006cited by this paper
• HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

  2006cited by this paper
• Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.

  2006cited by this paper
• Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox).

  2006cited by this paper
• Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat.

  2006cited by this paper
• BMP signaling controls PASMC KV channel expression in vitro and in vivo.

  2006cited by this paper
• Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung.

  2006cited by this paper
• Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension.

  2006cited by this paper
• Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

  2005cited by this paper
• Reversal of experimental pulmonary hypertension by PDGF inhibition.

  2005cited by this paper
• Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.

  2005cited by this paper
• PDH kinase inhibitors: a novel therapy for Type II diabetes?

  2005cited by this paper
• Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension

  2005cited by this paper
• Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells

  2005cited by this paper
• The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study).

  2005cited by this paper
• Methylation inhibitor therapy in the treatment of myelodysplastic syndrome

  2005cited by this paper
• Pulmonary Hypertension in Transgenic Mice Expressing a Dominant-Negative BMPRII Gene in Smooth Muscle

  2004cited by this paper
• Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.

  2004cited by this paper
• Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis

  2004cited by this paper
• Oxidative stress in severe pulmonary hypertension.

  2004cited by this paper
• Activation of K+ channels: an essential pathway in programmed cell death.

  2004cited by this paper
• Preferential Expression and Function of Voltage-Gated, O2-Sensitive K+ Channels in Resistance Pulmonary Arteries Explains Regional Heterogeneity in Hypoxic Pulmonary Vasoconstriction: Ionic Diversity in Smooth Muscle Cells

  2004cited by this paper
• O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1.

  2004cited by this paper
• Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation.

  2004cited by this paper
• Consomic rat model systems for physiological genomics.

  2004cited by this paper
• Manganese Superoxide Dismutase-Mediated Gene Expression in Radiation-Induced Adaptive Responses

  2003cited by this paper
• AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2.

  2003cited by this paper
• The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.

  2003cited by this paper
• In Vivo Gene Transfer of the O2-Sensitive Potassium Channel Kv1.5 Reduces Pulmonary Hypertension and Restores Hypoxic Pulmonary Vasoconstriction in Chronically Hypoxic Rats

  2003cited by this paper
• The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation*

  2003cited by this paper
• Cytochrome c activates K+ channels before inducing apoptosis.

  2002cited by this paper
• Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?

  2002cited by this paper
• Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats: Role of Increased Expression and Activity of Voltage-Gated Potassium Channels

  2002cited by this paper
• Diversity in Mitochondrial Function Explains Differences in Vascular Oxygen Sensing

  2002cited by this paper
• O2 Sensing in the Human Ductus Arteriosus: Regulation of Voltage-Gated K+ Channels in Smooth Muscle Cells by a Mitochondrial Redox Sensor

  2002cited by this paper
• Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia.

  2001cited by this paper
• Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms.

  2001cited by this paper
• Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells.

  2001cited by this paper
• Activation of K+ channels induces apoptosis in vascular smooth muscle cells.

  2001cited by this paper
• Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins

  2001cited by this paper
• Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis

  2001cited by this paper
• Alterations in a redox oxygen sensing mechanism in chronic hypoxia.

  2001cited by this paper
• Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease.

  2000cited by this paper
• Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation.

  2000cited by this paper
• Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family

  2000cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper
• Mitochondrial free radical generation, oxidative stress, and aging.

  2000cited by this paper
• Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype

  1998cited by this paper
• Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

  1998cited by this paper
• Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension.

  1998cited by this paper
• Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.

  1998cited by this paper
• Primary pulmonary hypertension between inflammation and cancer.

  1998cited by this paper
• Attenuated K+ channel gene transcription in primary pulmonary hypertension.

  1998cited by this paper
• Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.

  1998cited by this paper
• Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene.

  1997cited by this paper
• Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit*

  1996cited by this paper
• Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1.

  1995cited by this paper
• Increased plasma serotonin in primary pulmonary hypertension.

  1995cited by this paper
• A redox-based O2 sensor in rat pulmonary vasculature.

  1993cited by this paper
• An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.

  1992cited by this paper
• Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat.

  1992cited by this paper
• SOD2: A new type of tumor‐suppressor gene?

  1992cited by this paper
• Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

  1991cited by this paper
• Paradoxical constriction to platelets by arteries from rats with pulmonary hypertension.

  1991cited by this paper
• Simultaneous measurement of O2 radicals and pulmonary vascular reactivity in rat lung.

  1989cited by this paper
• H2O2 and cGMP may function as an O2 sensor in the pulmonary artery.

  1989cited by this paper
• Pulmonary artery pressure in rats with hereditary platelet function defect.

  1988cited by this paper
• Hydrogen peroxide elicits activation of bovine pulmonary arterial soluble guanylate cyclase by a mechanism associated with its metabolism by catalase.

  1987cited by this paper
• Redox status in the control of pulmonary vascular tone.

  1986cited by this paper
• Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria.

  1981cited by this paper

• EDIL3 regulates pulmonary artery smooth muscle cell proliferation and migration via integrin αVβ3/ERK1/2 axis in pulmonary hypertension.

  2025cites this paper
• Tet Methylcytosine Dioxygenase 2 ( TET2 ) Mutation Drives a Global Hypermethylation Signature in Patients With Pulmonary Arterial Hypertension (PAH): Correlation With Altered Gene Expression Relevant to a Common T Cell Phenotype

  2025cites this paper
• FAK mediates hypoxia‐induced pulmonary artery smooth muscle cell proliferation by modulating mitochondrial transcription termination factor 1/cyclin D1

  2024cites this paper
• Exploring the mechanisms of glycolytic genes involvement in pulmonary arterial hypertension through integrative bioinformatics analysis

  2024cites this paper
• Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics

  2024cites this paper
• Functions and novel regulatory mechanisms of key glycolytic enzymes in pulmonary arterial hypertension.

  2024cites this paper
• Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension

  2023cites this paper
• Glycometabolism reprogramming: Implications for cardiovascular diseases.

  2023cites this paper
• The Glycobiology of Pulmonary Arterial Hypertension

  2022cites this paper
• PHB2 Maintains the Contractile Phenotype of VSMCs by Counteracting PKM2 Splicing

  2022cites this paper
• Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension

  2022cites this paper
• Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.

  2022cites this paper
• Novel Pharmacological Targets for Pulmonary Arterial Hypertension.

  2021cites this paper
• Metabolic Reprogramming of the Right Ventricle and Pulmonary Arteries in a Flow-Associated Pulmonary Arterial Hypertension Rat Model

  2021cites this paper
• Identification of novel metabolic signatures potentially involved in the pathogenesis of COPD associated pulmonary hypertension

  2021cites this paper
• Metabolism of vascular smooth muscle cells in vascular diseases.

  2020cites this paper
• Docosahexaenoic acid inhibits Ca2+ influx and downregulates CaSR by upregulating microRNA‐16 in pulmonary artery smooth muscle cells

  2020cites this paper
• Pulmonary arterial hypertension specific therapy: The old and the new.

  2020cites this paper
• Osthole attenuates pulmonary arterial hypertension by the regulation of sphingosine 1-phosphate in rats.

  2020cites this paper
• Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.

  2020cites this paper
• Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature

  2019cites this paper
• Angiogenesis in Pulmonary Arterial Hypertension-Imaging of the Right Heart in a New Mouse Model

  2019cites this paper
• Altered hypoxia‐inducible factor–1α (HIF‐1α) signaling contributes to impaired angiogenesis in fetal lambs with persistent pulmonary hypertension of the newborn (PPHN)

  2019cites this paper
• Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension.

  2019cites this paper
• O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension

  2019cites this paper
• A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

  2018cites this paper
• Reversal of the Warburg effect with DCA in PDGF-treated human PASMC is potentiated by pyruvate dehydrogenase kinase-1 inhibition mediated through blocking Akt/GSK-3β signalling

  2018cites this paper
• Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension

  2018cites this paper
• Room With a View.

  2018cites this paper
• Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung

  2018cites this paper
• Reactive oxygen species induced Ca 2 (cid:2) influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension

  2018cites this paper
• Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

  2018cites this paper
• Functional Effects of Cigarette Smoke‐Induced Changes in Airway Smooth Muscle Mitochondrial Morphology

  2017cites this paper
• Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.

  2017cites this paper
• Drug-Induced Pulmonary Hypertension: The First 50 Years.

  2017cites this paper
• Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients

  2017cites this paper
• Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension.

  2017cites this paper
• PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway

  2017cites this paper
• Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension

  2017cites this paper
• Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension

  2017cites this paper
• Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung

  2016cites this paper
• Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular Remodeling.

  2016cites this paper
• Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension

  2016cites this paper
• Estrogen Metabolite 16&agr;-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism

  2016cites this paper
• Molecular pathogenesis and current pathology of pulmonary hypertension

  2016cites this paper
• The Warburg effect: A new story in pulmonary arterial hypertension.

  2016cites this paper
• Novel approaches to pulmonary arterial hypertension drug discovery

  2016cites this paper
• Rôle de SIRT1 et de la biogenèse mitochondriale dans la prolifération des cellules du muscle lisse de l'artère pulmonaire

  2015cites this paper
• Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells

  2015cites this paper
• Metabolic Dysfunction in Pulmonary Arterial Hypertension

  2015cites this paper
• O-Linked &bgr;-N-Acetylglucosamine Transferase Directs Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension

  2015cites this paper
• Redox Biology in Pulmonary Arterial Hypertension (2013 Grover Conference Series)

  2015cites this paper
• Smooth muscle acid‐sensing ion channel 1: pathophysiological implication in hypoxic pulmonary hypertension

  2015cites this paper
• The Role of HMGB1 in Cardiovascular Biology: Danger Signals

  2015cites this paper
• genes with relevance to human PAH analysis in the pulmonary arteries of mice identifies Serotonin transporter, sex, and hypoxia: microarray

  2015cites this paper
• The Estrogen Metabolite 16 OHE Exacerbates BMPR 2-Associated PAH Through miR-29-Mediated Modulation of Cellular Metabolism

  2015cites this paper
• Hypoxic Pulmonary Hypertension

  2014cites this paper
• Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.

  2014cites this paper
• Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension

  2014cites this paper
• Metabolomics reveals metabolite changes in acute pulmonary embolism.

  2014cites this paper
• Pulmonary Arterial Hypertension and Oxidative Stress

  2014cites this paper
• Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase.

  2014cites this paper
• Targeted therapies in pulmonary arterial hypertension.

  2014cites this paper
• Studies on Respiratory Disorders

  2014cites this paper
• Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension.

  2013cites this paper
• Regulation of pyruvate metabolism and human disease

  2013cites this paper
• Metabolic Remodeling and Mitochondrial Dysfunction in Maladaptive Right Ventricular Hypertrophy Secondary to Pulmonary Arterial hypertension

  2013cites this paper
• A Comprehensive Review: The Evolution of Animal Models in Pulmonary Hypertension Research; Are We there Yet?

  2013influential citation
• Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension

  2013cites this paper
• Disruption of Endothelial Cell Mitochondrial Bioenergetics in Lambs with Increased Pulmonary Blood Flow

  2013cites this paper
• Finding a job for dichloroacetate

  2013cites this paper
• Advances in the Management of Pulmonary Arterial Hypertension

  2013cites this paper
• Mitochondria in lung diseases

  2013cites this paper
• Pulmonary Hypertension Is a Probable NO/ONOO− Cycle Disease: A Review

  2013cites this paper
• A process-based review of mouse models of pulmonary hypertension

  2012cites this paper
• The key role of PGC-1α in mitochondrial biogenesis and the proliferation of pulmonary artery vascular smooth muscle cells at an early stage of hypoxic exposure

  2012cites this paper
• The imaging of pulmonary hypertension.

  2012cites this paper
• Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension.

  2012cites this paper
• Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.

  2012cites this paper
• FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate

  2012cites this paper
• The Molecular Genetics and Cellular Mechanisms Underlying Pulmonary Arterial Hypertension

  2012cites this paper
• Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming

  2012cites this paper
• A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

  2012cites this paper
• Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension

  2012influential citation
• Microarray studies in pulmonary arterial hypertension

  2011cites this paper
• Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.

  2011cites this paper
• Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

  2011cites this paper
• Oxidative injury is a common consequence of BMPR2 mutations

  2011cites this paper
• Oxidative injury is a common consequence of BMPR2 mutations.

  2010cites this paper
• Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: A transcriptional informatics analysis with validation

  2010cites this paper
• O-Linked β-N-Acetylglucosamine Transferase Directs Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension

  year unknowncites this paper